CCR 20th Anniversary commentary: stayin' alive-antiapoptotic proteins and breast cancer.

about

CCR 20th Anniversary commentary: stayin' alive-antiapoptotic proteins and breast cancer.

Item

http://www.wikidata.org/entity/Q43153984

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

CCR 20th Anniversary commentary: stayin' alive-antiapoptotic proteins and breast cancer.

@en

CCR 20th Anniversary commentary: stayin' alive-antiapoptotic proteins and breast cancer.

@nl

type

Item

label

CCR 20th Anniversary commentary: stayin' alive-antiapoptotic proteins and breast cancer.

@en

CCR 20th Anniversary commentary: stayin' alive-antiapoptotic proteins and breast cancer.

@nl

prefLabel

CCR 20th Anniversary commentary: stayin' alive-antiapoptotic proteins and breast cancer.

@en

CCR 20th Anniversary commentary: stayin' alive-antiapoptotic proteins and breast cancer.

@nl

P1476

CCR 20th Anniversary commentary: stayin' alive-antiapoptotic proteins and breast cancer.

@en

P2093

Douglas Yee

http://www.w3.org/2001/XMLSchema#string

P2860

Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics

Targeting survivin in cancer

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer.

S-phase fraction and breast cancer--a decade of experience.

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

Treatment of HER2-positive breast cancer: current status and future perspectives.

Treat cancers by targeting survivin: just a dream or future reality?

Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II stu

P304

665-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1158/1078-0432.CCR-14-2548

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Douglas Yee

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25691771

http://www.w3.org/2001/XMLSchema#string

P932

4333724

http://www.w3.org/2001/XMLSchema#string